James N. Gerson, M.D.
Assistant Professor of Medicine, Division Hematology and Oncology
Director, Cellular Therapy Program, University of Vermont Cancer Center
Director, CAR-T Services, University of Vermont Health Network
Hematologist and Medical Oncologist, UVM Health Network
89 Beaumont Ave
Given E214
Larner College of Medicine
Burlington, VT 05405
United States
- B.A., Yale University
- M.D., Case Western Reserve University School of Medicine
Department of Medicine, Division of Hematology and Medical Oncology
University of Vermont Cancer Center
BIO
James N. Gerson, MD is a board-certified hematologist-oncologist and the director of Cellular Therapy and director of the CART Program at the UVM Medical Center, as well as an assistant professor at the Larner College of Medicine. He specializes in the treatment of lymphoma, leukemia, and multiple myeloma. Specifically, he manages a variety of conditions, including non-Hodgkin lymphoma, Hodgkin lymphoma, acute and chronic leukemias, and hematologic cancer, and performs specialized procedures such as bone marrow biopsies.
Dr. Gerson is at the forefront of cellular therapy and CART-cell therapy. He helped to introduce this remarkable therapy to clinical practice in 2018, and has found it both exhilarating and rewarding to be involved in such a rapidly changing field. His published research on the subject can be found here.
A diagnosis of cancer is filled with uncertainty and fear. Dr Gerson and his team focus on helping patients navigate their diagnosis and find hope through discussing treatment options and, in many cases, the chance of a cure. He strives to integrate new technologies with each patient’s personal goals and values, to give them the best chance for a good outcome.
Dr. Gerson's postdoctoral training
Fellowship in Hematology and Medical Oncology, Fox Chase Cancer Center, Temple University
Residency in Internal Medicine, Stanford University Hospitals and Clinic
Publications
Dr. Gerson's publications on PubMed
Area(s) of expertise
Lymphoma
Cellular Therapy
Bio
James N. Gerson, MD is a board-certified hematologist-oncologist and the director of Cellular Therapy and director of the CART Program at the UVM Medical Center, as well as an assistant professor at the Larner College of Medicine. He specializes in the treatment of lymphoma, leukemia, and multiple myeloma. Specifically, he manages a variety of conditions, including non-Hodgkin lymphoma, Hodgkin lymphoma, acute and chronic leukemias, and hematologic cancer, and performs specialized procedures such as bone marrow biopsies.
Dr. Gerson is at the forefront of cellular therapy and CART-cell therapy. He helped to introduce this remarkable therapy to clinical practice in 2018, and has found it both exhilarating and rewarding to be involved in such a rapidly changing field. His published research on the subject can be found here.
A diagnosis of cancer is filled with uncertainty and fear. Dr Gerson and his team focus on helping patients navigate their diagnosis and find hope through discussing treatment options and, in many cases, the chance of a cure. He strives to integrate new technologies with each patient’s personal goals and values, to give them the best chance for a good outcome.
Dr. Gerson's postdoctoral training
Fellowship in Hematology and Medical Oncology, Fox Chase Cancer Center, Temple University
Residency in Internal Medicine, Stanford University Hospitals and Clinic
Publications
Areas of Expertise
Lymphoma
Cellular Therapy